OpenAI's AGI deployment CEO Fidji Simo is taking medical leave for several weeks due to a neuroimmune condition, with president Greg Brockman temporarily overseeing product leadership. CMO Kate Rouch is also stepping down to focus on her health, marking another executive shift at the company. The changes come amid ongoing efforts to develop OpenAI's super app and manage AGI deployment strategies.
Background
OpenAI is a leading AI research company known for developing advanced models like GPT-4 and pursuing artificial general intelligence (AGI). Executive movements at such organizations often reflect strategic shifts or internal challenges in high-stakes tech development.
- Source
- The Verge
- Published
- Apr 4, 2026 at 04:22 AM
- Score
- 5.0 / 10